Personalized treatment linked to better Phase I outcomes

Researchers at the University of California San Diego and colleagues found that use of personalized cancer therapies improved outcomes

Read the full 197 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE